|
ADRBK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.041000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.082400E-01 |
| Normal-vs-Stage2 |
9.064200E-02 |
| Normal-vs-Stage3 |
5.619200E-01 |
| Normal-vs-Stage4 |
5.604500E-03 |
| Stage1-vs-Stage2 |
2.660200E-02 |
| Stage1-vs-Stage3 |
9.873200E-01 |
| Stage1-vs-Stage4 |
3.863500E-02 |
| Stage2-vs-Stage3 |
4.844200E-02 |
| Stage2-vs-Stage4 |
7.439300E-04 |
| Stage3-vs-Stage4 |
1.045050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.409800E-01 |
| Normal-vs-AfricanAmerican |
6.867000E-01 |
| Normal-vs-Asian |
9.631000E-01 |
| Caucasian-vs-AfricanAmerican |
9.868000E-01 |
| Caucasian-vs-Asian |
8.650000E-01 |
| AfricanAmerican-vs-Asian |
8.933800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.338200E-01 |
| Normal-vs-Female |
9.036800E-01 |
| Male-vs-Female |
7.077200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.741200E-01 |
| Normal-vs-Extreme_Weight |
5.095600E-01 |
| Normal-vs-Obese |
8.080400E-01 |
| Normal-vs-Extreme_Obese |
6.619500E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.834600E-01 |
| Normal_Weight-vs-Obese |
1.257820E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.942400E-01 |
| Extreme_Weight-vs-Obese |
3.581200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.758360E-01 |
| Obese-vs-Extreme_Obese |
5.495900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.530600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.996600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.640400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.642800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.895000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.274600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.003600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.129800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.290200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.344600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.902000E-01 |
| Normal-VS-Type2 PRCC |
7.259800E-01 |
| Normal-VS-KIRP CIMP |
3.354400E-01 |
| Normal-VS-Unclassified PRCC |
2.969800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.771600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.371000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.991610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.362400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.851040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.598800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.991000E-01 |
| Normal-vs-N1 |
5.922200E-01 |
| Normal-vs-N2 |
8.211900E-02 |
| N0-vs-N1 |
6.342600E-01 |
| N0-vs-N2 |
1.863390E-01 |
| N1-vs-N2 |
1.870240E-01 |
|
|
